Works by Jang, Hak‐Chul


Results: 92
    1
    2
    3
    4
    5
    6
    7

    A 52‐week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add‐on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1535, doi. 10.1111/dom.13256
    By:
    • for the Gemigliptin Study 006 Group;
    • Jung, Chan‐Hee;
    • Rhee, Eun‐Jung;
    • Lee, Won‐Young;
    • Min, Kyung Wan;
    • Shivane, Vyankatesh K.;
    • Sosale, Aravind R.;
    • Jang, Hak Chul;
    • Chung, Choon Hee;
    • Nam‐Goong, Il Seong
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.

    Published in:
    Journal of Diabetes Investigation, 2014, v. 5, n. 6, p. 701, doi. 10.1111/jdi.12201
    By:
    • Kim, Hye‐soon;
    • Kim, Doo‐man;
    • Cha, Bong‐soo;
    • Park, Tae Sun;
    • Kim, Kyoung‐ah;
    • Kim, Dong‐lim;
    • Chung, Choon Hee;
    • Park, Jeong‐hyun;
    • Jang, Hak Chul;
    • Choi, Dong‐seop
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Recombinant human thyrotropin-stimulated thyroglobulin level at the time of radioactive iodine ablation is an independent prognostic marker of differentiated thyroid carcinoma in the setting of prophylactic central neck dissection.

    Published in:
    Clinical Endocrinology, 2016, v. 85, n. 3, p. 459, doi. 10.1111/cen.13029
    By:
    • Moon, Jae Hoon;
    • Choi, June Young;
    • Jeong, Woo‐Jin;
    • Ahn, Soon‐Hyun;
    • Lee, Won Woo;
    • Kim, Kyoung Min;
    • Choi, Sung Hee;
    • Lim, Soo;
    • Park, Young Joo;
    • Yi, Ka Hee;
    • Park, Do Joon;
    • Jang, Hak Chul
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea.

    Published in:
    Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 1495, doi. 10.2147/DMSO.S334944
    By:
    • Kim, Hye Soon;
    • Yu, Jae Myung;
    • Jang, Hak Chul;
    • Choi, Eui Kwang;
    • Park, Jeong Hyun;
    • Shon, Ho Sang;
    • Chung, Choon Hee;
    • Park, Keun-Gyu;
    • Cho, Jae Hyoung;
    • Kim, Won;
    • Lee, Kyoung Hwa;
    • Lee, Jee Hyun;
    • Yoo, Soon Jib
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50